IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MWG Management Ltd.

Q3 2025 Holdings

Filed 2025-11-12 | 3 holdings | $81.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Beam Therapeutics Inc(BEAM)COM07373V105$55.0M2,266,93467.7%
Lyell Immunopharma Inc(LYEL)COM NEW55083R203$16.4M1,008,11620.1%
Prime Medicine Inc(PRME)COM74168J101$9.9M1,792,21012.2%